Shortage of plasma-derived products: a looming crisis?

被引：21
|
作者：
Li Covington, Mischa [1 ]
Voma, Chesinta [2 ]
Stowell, Sean R. [1 ,2 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Joint Program Transfus Med, Dept Pathol, 630E New Res Bldg, Boston, MA 02115 USA
[2] Qualtex Labs, Norcross, GA USA
来源：
BLOOD | 2022年 / 139卷 / 21期
关键词：
RANDOMIZED-TRIAL; FACTOR-VIII; BLOOD; FREQUENCY;
D O I：
10.1182/blood.2021015370
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3222 / 3225
页数：4
相关论文
共 50 条
  • [1] Plasma-derived products: Biological therapeutic products
    Follea, G
    Cazenave, JP
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1997, 4 (02) : 227 - 240
  • [2] An industry perspective on plasma-derived products
    von Hoegen, I
    PDA/EMEA EUROPEAN VIRUS SAFETY FORUM, 2004, 118 : 31 - 35
  • [3] Plasma-Derived Medicinal Products in Nigeria
    Mathew Folaranmi Olaniyan
    Musa Abidemi Muhibi
    SN Comprehensive Clinical Medicine, 5 (1)
  • [4] Challenges for Plasma-Derived Medicinal Products
    Moog, Rainer
    Dehmer-Laitinen, Teija
    Taborski, Uwe
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2023, 50 (06) : 559 - 560
  • [5] Challenges for Plasma-Derived Medicinal Products
    Strengers, Paul F. W.
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2023, 50 (02) : 116 - 122
  • [6] Nanofiltration of plasma-derived biopharmaceutical products
    Burnouf, T
    Radosevich, M
    HAEMOPHILIA, 2003, 9 (01) : 24 - 37
  • [7] The safety of plasma-derived products in Australia
    Guirguis, Andrew
    Wood, Erica
    AUSTRALIAN PRESCRIBER, 2010, 33 (03) : 76 - 79
  • [8] Plasma-derived industry and plasma-derived medicinal products in the Italian National Blood Transfusion Service
    De Silvestro, Giustina
    Marson, Piero
    Breda, Antonio
    De Angelis, Vincenzo
    TRANSFUSION AND APHERESIS SCIENCE, 2019, 58 (05) : 545 - 549
  • [9] Viral risks of plasma-derived medicinal products
    Janssen, M. P.
    Cuijpers, T. M.
    Van der Poel, C. L.
    Over, J.
    TRANSFUSION, 2006, 46 (09) : 108A - 108A
  • [10] Viral risks of plasma-derived medicinal products
    Janssen, M. P.
    van der Poel, C. L.
    van Hout, B. A.
    Over, J.
    Cuijpers, H. T. M.
    VOX SANGUINIS, 2006, 91 : 5 - 5
12345